Studies related to Anxiety and Valeriana officinalis

Effect Of Valepotriates (valerian Extract) In Generalized Anxiety Disorder: A Randomized Placebo-controlled Pilot Study

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 36
Sex Both Genders
Age Range 30-44, 45-64
Notes for this study:
Supplementation of valerian valepotriates at 81.3mg daily for four weeks in persons with diagnosed generalized anxiety disorder (GAD) compared to both placebo and diazepam noted that the valepotriates were not significantly effective relative to placebo despite a positive trend.

There was no significant difference between valepotriates and diazepam either on HAM-A (a rating scale), although diazepam outperformed valepotriates on the STAI-Trait rating scale.